XML 107 R93.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Mar. 21, 2024
Jul. 30, 2024
Jul. 19, 2024
Jun. 27, 2024
Jan. 23, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Apr. 22, 2024
Purchase price for the acquisition amounted         $ 637,080        
Consideration share         280,000        
Bid price     closing bid price of $1.00 or greater per common share for ten (10) consecutive business days from July 5, 2024 to July 18, 2024            
Minimum bid price     $ 1.00            
Closing bid of shares of common stock     $ 1.00            
Fair value of shares         $ 319,200        
Settelment amount         317,880        
Intangible asset         $ 637,080        
Common stock share sold 901,488         901,488      
Gross proceeds from share sold $ 648,893           $ 0 $ 6,000,000  
Common stock, par value           $ 0.001 $ 0.001 $ 0.001 $ 0.001
Deadline report   Nasdaq further extended the filing deadline through October 14, 2024              
Notification Letter [Member]                  
Bid price     closing bid price of $1.00 or greater per common share for ten consecutive business days from July 5, 2024 to July 18, 2024            
Minimum bid price     $ 1.00            
Placement Agent [Member]                  
Fees and other commissions 23,153         $ 19,467      
Net proceeds $ 625,740         $ 629,426      
Pharmalink [Member]                  
First purchase order       130,000          
First year purchase order       500,000          
Over year five purchase order       3,000,000